Presseinformationen weltweit an Journalisten und Leser verbreiten
The LMU Center for NanoScience (CeNS) and four spin-off companies, including ibidi, have joined together to reward the best innovative theses on nanotechnology with the Nano Innovation Award 2019. Two junior researchers from Bayreuth and Munich have been honored this Mehr
ibidi has been awarded valuable funding from BioM “Start.Smart.Global” to break into the challenging life science markets of Japan and Korea. They were one of only twelve ambitious European companies selected, which plan on expanding into these two Asian markets Mehr
With their latest reagent, mRNA LifeAct-TagGFP2, ibidi has created a rapid, non-invasive and non-toxic solution for the visualization of filamentous actin (F-actin) in living and fixed eukaryotic cells. As a key component of the cytoskeleton, F-actin orchestrates many crucial cellular Mehr
Lab automatization and high throughput screening are being raised to the next level with ibidi’s latest labware development, the µ-Plate 384 Well Clear. This novel microtiter plate combines automated cell cultivation with high-resolution microscopy. The flat, thin polymer coverslip bottom Mehr
ibidi introduces a fast, new web-based tool, ACAS (Automated Cellular Analysis System), which offers extremely quick and reliable analysis of wound healing and angiogenesis assays. This lean and efficient software is the latest addition to ibidi’s already innovative product portfolio, Mehr
Fuse-It-siRNA is an innovative new transfection reagent that enables rapid and efficient gene silencing with the highest biocompatibility, even in sensitive and difficult-to-transfect cells, such as primary keratinocytes. ibidi’s novel method for endosome-independent siRNA transfection fully retains cellular functionality and Mehr